NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy

Nik M Mustapha1, Joanna M Tarr, Eva M Kohner

  • 1Forest Research Institute Malaysia (FRIM), 52109 Kepong, Selangor Darul Ehsan, Malaysia.

Insights

NADPH oxidase-derived reactive oxygen species (ROS), not mitochondrial ROS, drive high glucose-induced pericyte apoptosis. Apocynin, an NADPH oxidase inhibitor, prevented ROS generation, Nepsilon-(carboxymethyl) lysine formation, and cell death in diabetic retinopathy models.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Diabetic Complications

Background:

  • Diabetic retinopathy involves pericyte apoptosis, a process potentially linked to oxidative stress.
  • Reactive oxygen species (ROS) generated by NADPH oxidase and mitochondria are implicated in cellular damage.

Purpose of the Study:

  • To investigate whether NADPH oxidase or mitochondria are the primary source of ROS causing high glucose-induced pericyte apoptosis.
  • To evaluate the therapeutic potential of targeting NADPH oxidase versus mitochondria in this context.

Main Methods:

  • Pericyte apoptosis was induced by high glucose (25 mM) and measured via caspase-3 activity.
  • NADPH oxidase localization was confirmed using Western blot and cytochrome C reduction assays.
  • ROS production, intracellular glucose, and Nepsilon-(carboxymethyl) lysine (CML) levels were quantified.
  • Apocynin (NADPH oxidase inhibitor) and Mitoquinol 10 nitrate (MitoQ; mitochondrial antioxidant) were used to assess ROS source.

Main Results:

  • High glucose significantly increased pericyte apoptosis, intracellular glucose, and CML formation.
  • Apoptosis correlated with increased gp91phox expression, NADPH oxidase activity, and ROS production.
  • Apocynin treatment significantly reduced ROS generation, CML formation, and apoptosis.
  • MitoQ did not significantly affect these parameters, indicating mitochondria were not the primary ROS source.

Conclusions:

  • NADPH oxidase-derived ROS, not mitochondrial ROS, are the key drivers of high glucose-induced pericyte apoptosis.
  • Targeting NADPH oxidase may be a viable therapeutic strategy for diabetic retinopathy.